Skip to main content

Sickle Cell Disease and cannabis in Alaska

The state currently does not list this condition as qualifying, and the program does not provide open-ended physician discretion to add conditions. Verify with the state regulator, because programs change.

Not on the qualifying list
✗ No
LEGAL
Up to 1 oz usable canna…
POSSESSION
$25/yr
STATE FEE
14–45 d
TIMELINE
Not on the qualifying list. The state currently does not list this condition as qualifying, and the program does not provide open-ended physician discretion to add conditions. Verify with the state regulator, because programs change.

Alaska statute and program

The Alaska Medical Marijuana Registry is the operating authority for Alaska patient certification. The authoritative legal text is: Alaska Statutes Title 17 Chapter 38: Regulation of Marijuana. The program portal is at Alaska Medical Marijuana Registry.

What the evidence says about cannabis and Sickle Cell Disease

Sickle cell disease (SCD) is a group of inherited red blood cell disorders caused by mutations in the hemoglobin gene. Red cells assume a rigid sickle shape under low-oxygen conditions, leading to chronic hemolytic anemia, episodic vaso-occlusive pain crises, stroke risk, acute chest syndrome, and progressive end-organ damage. SCD disproportionately affects people of African, Mediterranean, and South Asian descent.

For the full evidence base, including the NASEM tier, randomized trial summaries, and symptom-domain breakdown, read the mmjnow Sickle Cell Disease page.

How to qualify in Alaska

The Alaska Medical Marijuana Registry requires the following registration steps for a Sickle Cell Disease patient (or any qualifying diagnosis):

  1. Get a Written Physician Statement from an Alaska-licensed physician. Under AS 17.37 (Alaska Medical Use of Marijuana Act, Ballot Measure 8 of 1998), any Alaska-licensed physician (MD or DO) may complete the Written Physician Statement attesting that the patient has been diagnosed with a debilitating medical condition (cancer, glaucoma, HIV/AIDS, MS, severe and chronic pain, severe nausea, seizures, severe and persistent muscle spasms, or cachexia) and that the patient may benefit from medical use of marijuana.
  2. Apply by mail to the Alaska Medical Marijuana Registry. The patient mails the completed Application for Registry Identification Card, the Written Physician Statement, a copy of an Alaska driver license or state ID, and the registration fee to the Alaska Department of Health, Division of Public Health, Bureau of Vital Statistics. Alaska does not currently offer an online application option.
  3. Pay the $25 state registration fee. The annual Alaska medical marijuana registry identification card fee is $25 ($20 for renewal). Designated caregiver registration is an additional $25 and requires a state criminal background check; caregivers must be Alaska residents and must not have a prior felony conviction.
  4. Receive the card and possess up to 1 ounce. Alaska medical marijuana registry cards are typically issued within 30 days of complete application. Registered patients may possess up to 1 ounce of usable cannabis and cultivate up to 6 plants (with no more than 3 mature) for personal medical use. Alaska does not operate a state-licensed medical dispensary system separate from adult-use retail. Adult-use retail is legal statewide for adults 21+. Alaska does not honor out-of-state medical cards.
State registration fee
$25
Physician visit (typical)
$150–$300
Certification to card
14–45 days
Out-of-state patients
Not eligible
Minors
Eligible with caregiver

For full Alaska registration steps, fees, and reciprocity rules, see the Alaska cannabis-laws page.

ICD-10 code

A certifying physician documenting Sickle Cell Disease for the Alaska medical cannabis program will typically record ICD-10 D57.1 or SNOMED-CT 417357006 in the patient's record. The state registry does not itself collect ICD-10 codes in most programs, but the physician's chart is the audit trail if the certification is later reviewed.

Frequently asked questions

Does Alaska list Sickle Cell Disease as a qualifying condition for medical cannabis?

No. Alaska's qualifying-condition list does not currently include Sickle Cell Disease, and the state's program does not give physicians open-ended discretion to add conditions outside the list. Patients with Sickle Cell Disease in Alaska have limited in-state pathways under the medical program as written. Options to verify and pursue include: petitioning the state regulator to add the condition (where the statute permits public petitions); consulting a physician about whether a co-occurring listed condition could support certification; or reviewing whether the state's program is undergoing legislative expansion. Alaska program rules change, so verify the current list with the regulator before drawing a final conclusion.

How do I get a Alaska medical marijuana card for Sickle Cell Disease?

Because Alaska does not currently list Sickle Cell Disease as a qualifying condition, a card for Sickle Cell Disease alone may not be obtainable in-state under the program rules as written. Step one is finding a physician licensed in Alaska who is registered with Alaska Medical Marijuana Registry and willing to evaluate Sickle Cell Disease cases. Step two is collecting your records (diagnosis documentation, treatment history, and the ICD-10 code your physician will use) and bringing them to the certification visit. Step three is the physician's certification through the state registry, followed by the patient registration application, state fee, and waiting period before the card is issued. Alaska does not honor out-of-state cards, so the certification process has to originate inside the state. Verify the patient minimum age with the state program before applying. The authoritative source for the current process is the Alaska Medical Marijuana Registry site at https://health.alaska.gov/dph/VitalStats/Pages/marijuana.aspx; the state updates fees, forms, and physician registration rules periodically.

What does the evidence say about cannabis for Sickle Cell Disease?

For Sickle Cell Disease, evidence is described as limited (a small number of supportive studies, often underpowered or focused on narrow symptom domains). The mmjnow condition page for Sickle Cell Disease lays out the current evidence base, including the citations underlying that evidence tier — typically the National Academies of Sciences, Engineering, and Medicine consensus reports, federal agency guidance, and peer-reviewed reviews. Evidence quality is independent of state law: a state can list a condition for which evidence is limited, and a state can decline to list a condition for which evidence is strong. Patients deciding whether to pursue medical cannabis for Sickle Cell Disease should review the underlying evidence (linked on the condition page) and discuss expected benefit, dosing, and risk with a clinician familiar with both Sickle Cell Disease and cannabinoid pharmacology. Cannabis is not a substitute for evidence-based first-line treatments for Sickle Cell Disease; the evidence position above describes whether trial data supports its use, not whether it should replace standard care.

Sources

  1. Alaska Statutes Title 17 Chapter 38: Regulation of Marijuanaaccessed May 16, 2026
  2. Alaska Marijuana Control Board (Alcohol and Marijuana Control Office)accessed May 16, 2026
  3. Alaska Department of Health: Medical Marijuana Registryaccessed May 16, 2026
  4. Wikipedia: Cannabis in Alaskaaccessed May 16, 2026
  5. NIH National Heart, Lung, and Blood Institute: Sickle Cell Diseaseaccessed May 15, 2026
  6. NIH NCCIH: Cannabis (Marijuana) and Cannabinoidsaccessed May 15, 2026